The field of biochemical engineering is witnessing an innovative approach with the development of fine-bubble engineering techniques. By focusing on the manipulation of both nanobubbles (NBs) and microbubbles (MBs), researchers aim to improve the efficiency and effectiveness of various bioprocess
Chronic obstructive pulmonary disease (COPD) is a progressive respiratory condition that profoundly impacts patients' quality of life and incurs substantial healthcare costs. Effective management of COPD often necessitates the use of inhaled medications, such as corticosteroids, long-acting
In an era where precision medicine is becoming increasingly relevant, the integration of digital technologies in clinical trials has emerged as a critical advancement that is reshaping the landscape of clinical research and development (R&D). The transformative role of technology in clinical trials
Mirror bacteria, theoretical organisms composed of chiral molecules that are mirror images of those found in natural life forms, have sparked significant debate within the scientific community. These organisms hinge on the concept of chirality, where "right-handed" amino acids and "left-handed"
MilliporeSigma, the Life Science business of Merck KGaA in the U.S. and Canada, has announced a definitive agreement to acquire HUB Organoids Holding B.V. (HUB). This acquisition marks a significant step forward in enhancing their 2D and 3D cell culture portfolio with the innovative technology of
The pharmaceutical industry is currently experiencing a transformative period marked by evolving clinical trial dynamics, increased R&D investment, and significant post-pandemic adjustments. This transformation is primarily driven by the complexities of modern trials, the demands for personalized
